Finnegan Upholds Tier 1 Marks in 2023 LMG Life Sciences Rankings

FOR IMMEDIATE RELEASE
September 21, 2023

WASHINGTON, DC—LMG Life Sciences released its 2023 rankings, and Finnegan continued to retain Tier 1 positions for all major IP categories: Patent Prosecution; Patent Strategy and Management; General Patent Litigation; and Hatch-Waxman Patent Litigation (Branded). Finnegan has been at the top of the LMG Life Sciences rankings for 13 consecutive years.

The following attorneys were also recognized for their work in the life sciences sector:

Michele C. Bosch - General Patent Litigation, Patent Strategy & Management

L. Scott Burwell- General Patent Litigation, Hatch-Waxman, Patent Litigation

Bryan C. Diner - Patent Strategy & Management, Hatch-Waxman Patent Litigation

Mark J. Feldstein, Ph.D. - General Patent Litigation, Hatch-Waxman Patent Litigation

Jeffrey M. Jacobstein - Patent Prosecution, Patent Strategy & Management

J. Michael Jakes - General Patent Litigation, Patent Strategy & Management

Charles E. Lipsey - General Patent Litigation, Hatch-Waxman Patent Litigation, Hall of Fame

John D. Livingstone - Hatch-Waxman Patent Litigation

Jill K. MacAlpine, Ph.D. - General Patent Litigation, Patent Prosecution, Patent Strategy & Management

Leslie A. McDonell - Patent Prosecution, Patent Strategy & Management

James B. Monroe - General Patent Litigation

William B. Raich, Ph.D. - General Patent Litigation

M. David Weingarten, Ph.D. - Patent Prosecution, Patent Strategy & Management

At the 2023 LMG Life Sciences Awards event in New York held earlier this month, Finnegan took home the awards for Intellectual Property Boutique Firm of the Year and Inter Partes Review Firm of the Year. Partner James Monroe received the award for Hatch-Waxman Litigator of the Year – Branded.

Finnegan’s Life Sciences practice includes more than 250 attorneys and professionals with in-depth technical experience in the biologics, biotechnology, branded Hatch-Waxman (ANDA), digital health, medical device and diagnostics, and pharmaceutical spaces. Many of Finnegan’s IP professionals hold advanced degrees in relevant scientific disciplines such as biology, chemistry, biochemistry, medicine, pharmacology, biomedical engineering, or electrical engineering and a significant number joined Finnegan after holding positions in industry, at universities, or as examiners with the U.S. Patent and Trademark Office.

Contacts

Erika Arner, Managing Partner
erika.arner@finnegan.com

Anand K. Sharma, Chair
anand.sharma@finnegan.com

About Finnegan
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP is one of the largest IP law firms in the world. From offices in Atlanta, Boston, London, Munich, Palo Alto, Reston, Seoul, Shanghai, Taipei, Tokyo, and Washington, DC, the firm practices European, German, UK, and U.S. IP law. In addition to services related to all aspects of patent, trademark, and copyright law, including counseling, prosecution, licensing, and litigation, Finnegan provides counseling and litigation services in advertising, privacy, and a wide spectrum of additional IP-adjacent commercial matters, including trade secrets, international trade, the Internet, e-commerce, government contracts, antitrust, and unfair competition. For additional information on the firm, please visit www.finnegan.com and follow us on LinkedIn.